CytomX Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2017
Total Assets: $397.6M
Liabilities Breakdown FY2017
Total Liabilities: $327.7M
Asset Breakdown
Total Assets: $397.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $177.5M | 44.6% |
| Accounts Receivable | $10.1M | 2.5% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.2M | 1.1% |
| Goodwill | $949.0K | 0.2% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $204.8M | 51.5% |
Liabilities Breakdown
Total Liabilities: $327.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.2M | 1.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $323.5M | 98.7% |